The microbiome modulates the tumor macroenvironment

Susan E Erdman1, Theofilos Poutahidis2

  • 1Division of Comparative Medicine; Massachusetts Institute of Technology; Cambridge, MA USA.

Oncoimmunology
|July 23, 2014
PubMed

Insights

Gut microbes influence distant tumors by modulating host immunity and neuroendocrine signals. This research introduces holobiont therapeutic engineering for novel tumor microenvironment treatments.

Area of Science:

  • Microbiology
  • Immunology
  • Oncology

Background:

  • The tumor microenvironment is complex, with systemic networks offering therapeutic targets.
  • Emerging research highlights the gut microbiome's role in cancer development and progression.

Purpose of the Study:

  • To explore how gut microbes impact distant preneoplastic lesions.
  • To establish a new therapeutic strategy based on host-microbe interactions.

Main Methods:

  • Investigated the modulation of host immune and neuroendocrine factors by gut microbes.
  • Analyzed the impact of these factors on preneoplastic lesion fate.

Main Results:

  • Gut microbes significantly alter systemic immune and neuroendocrine profiles.
  • Microbial influence directs preneoplastic lesions towards either malignancy or regression.

Conclusions:

  • Gut microbiota represent a critical factor in determining tumor progression.
  • Holobiont therapeutic engineering offers a novel approach to cancer treatment by targeting the gut-host-tumor axis.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

2.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Tumor Progression02:07

Tumor Progression

3.1K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
162